Clinical trial

Angiogenic Imaging in Pulmonary Arterial Hypertension

NCT03166306

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-05-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2018-05-01Date precision: day

Registry last updated2021-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Exercise Associated Pulmonary Arterial Hypertensionunresolved

Interventions

PET-CT Imaging with [89Zr]-bevacizumabDIAGNOSTIC_TEST

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03166306 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.